Dubow Adam
Insider CIK 1744507 · BMY SVP,ChiefCompliance&EthicsOff. · DAWN General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 105,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 8,889 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 5,250 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 25,816 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 40,565 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 65,625 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 309,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer | 2026-04-23 | 2026-04-23 | 72,694 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2026-02-17 | 2026-02-18 | 6,395 | $11.60 | $74.2K | 72,694 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 3,687 | — | $0 | 40,565 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 4,375 | — | $0 | 65,625 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 3,688 | — | $0 | 25,816 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,750 | — | $0 | 5,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 2,963 | — | $0 | 8,889 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 4,375 | — | $0 | 79,089 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 2,963 | — | $0 | 65,589 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 3,687 | — | $0 | 74,714 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 3,688 | — | $0 | 71,027 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 1,750 | — | $0 | 67,339 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2026-01-30 | 2026-01-30 | 70,000 | — | $0 | 70,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2026-01-30 | 2026-01-30 | 105,000 | — | $0 | 105,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-11-17 | 2025-11-18 | 4,319 | $8.91 | $38.5K | 62,626 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 3,687 | — | $0 | 44,252 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 3,687 | — | $0 | 29,504 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 1,750 | — | $0 | 7,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 2,963 | — | $0 | 11,852 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 2,963 | — | $0 | 57,821 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 1,750 | — | $0 | 59,571 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 3,687 | — | $0 | 63,258 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 3,687 | — | $0 | 66,945 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 309,000 | — | $0 | 309,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-08-18 | 2025-08-19 | 4,365 | $6.77 | $29.6K | 54,858 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 2,963 | — | $0 | 14,815 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 1,750 | — | $0 | 8,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 3,687 | — | $0 | 33,191 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 3,687 | — | $0 | 47,939 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 2,963 | — | $0 | 50,099 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 1,750 | — | $0 | 51,849 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 3,687 | — | $0 | 55,536 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 3,687 | — | $0 | 59,223 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-05-16 | 2025-05-19 | 4,552 | $6.26 | $28.5K | 47,136 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 3,687 | — | $0 | 36,878 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 1,750 | — | $0 | 10,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 2,962 | — | $0 | 17,778 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 3,687 | — | $0 | 51,626 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 3,687 | — | $0 | 51,688 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 3,687 | — | $0 | 48,001 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 1,750 | — | $0 | 44,314 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 2,962 | — | $0 | 42,564 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-02-18 | 2025-02-21 | 4,646 | $11.96 | $55.6K | 39,602 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-02-15 | 2025-02-21 | 3,687 | — | $0 | 40,565 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-02-15 | 2025-02-21 | 3,687 | — | $0 | 55,313 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-02-15 | 2025-02-21 | 1,750 | — | $0 | 12,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-02-15 | 2025-02-21 | 2,962 | — | $0 | 20,740 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-02-15 | 2025-02-21 | 3,687 | — | $0 | 40,561 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-02-15 | 2025-02-21 | 3,687 | — | $0 | 44,248 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-02-15 | 2025-02-21 | 1,750 | — | $0 | 36,874 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-02-15 | 2025-02-21 | 2,962 | — | $0 | 35,124 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-01-15 | 2025-01-31 | 59,000 | — | $0 | 59,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-01-15 | 2025-01-31 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-11-18 | 2024-11-19 | 3,165 | $13.21 | $41.8K | 32,162 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-11-15 | 2024-11-19 | 3,687 | — | $0 | 44,252 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-11-15 | 2024-11-19 | 1,750 | — | $0 | 14,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-11-15 | 2024-11-19 | 2,962 | — | $0 | 23,702 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-11-15 | 2024-11-19 | 3,687 | — | $0 | 35,327 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-11-15 | 2024-11-19 | 2,962 | — | $0 | 29,890 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-11-15 | 2024-11-19 | 1,750 | — | $0 | 31,640 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-08-16 | 2024-08-19 | 3,202 | $14.00 | $44.8K | 26,928 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-08-15 | 2024-08-19 | 1,750 | — | $0 | 15,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-08-15 | 2024-08-19 | 3,687 | — | $0 | 47,939 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-08-15 | 2024-08-19 | 2,962 | — | $0 | 26,664 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-08-15 | 2024-08-19 | 1,750 | — | $0 | 26,443 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-08-15 | 2024-08-19 | 3,687 | — | $0 | 30,130 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-08-15 | 2024-08-19 | 2,962 | — | $0 | 24,693 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-05-16 | 2024-05-17 | 3,253 | $16.08 | $52.3K | 21,731 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-05-15 | 2024-05-17 | 2,962 | — | $0 | 29,626 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-05-15 | 2024-05-17 | 1,750 | — | $0 | 17,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-05-15 | 2024-05-17 | 3,687 | — | $0 | 51,626 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-05-15 | 2024-05-17 | 1,750 | — | $0 | 21,297 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-05-15 | 2024-05-17 | 3,687 | — | $0 | 24,984 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-05-15 | 2024-05-17 | 2,962 | — | $0 | 19,547 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2024-02-16 | 2024-02-20 | 3,242 | $15.25 | $49.4K | 16,585 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-02-15 | 2024-02-20 | 2,962 | — | $0 | 32,588 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-02-15 | 2024-02-20 | 1,750 | — | $0 | 19,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2024-02-15 | 2024-02-20 | 3,687 | — | $0 | 55,313 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-02-15 | 2024-02-20 | 2,962 | — | $0 | 14,390 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-02-15 | 2024-02-20 | 3,687 | — | $0 | 19,827 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2024-02-15 | 2024-02-20 | 1,750 | — | $0 | 16,140 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-01-05 | 2024-01-09 | 59,000 | — | $0 | 59,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-01-05 | 2024-01-09 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2023-11-16 | 2023-11-17 | 5,313 | $11.69 | $62.1K | 11,428 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-11-15 | 2023-11-17 | 11,850 | — | $0 | 35,550 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2023-11-15 | 2023-11-17 | 1,750 | — | $0 | 21,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-11-15 | 2023-11-17 | 11,850 | — | $0 | 14,991 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2023-11-15 | 2023-11-17 | 1,750 | — | $0 | 16,741 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | S Sale | 2021-07-30 | 2021-08-03 | 2,466 | $67.90 | $167.4K | 13,777 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | S Sale | 2021-05-05 | 2021-05-07 | 3,119 | $64.21 | $200.3K | 16,243 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-03-10 | 2021-03-12 | 3,981 | — | $0 | 3,981 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-03-10 | 2021-03-12 | 1,062 | — | $0 | 2,124 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-03-10 | 2021-03-12 | 2,495 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-03-10 | 2021-03-12 | 452 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-03-10 | 2021-03-12 | 5,972 | — | $0 | 5,972 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-03-10 | 2021-03-12 | 980 | — | $0 | 2,943 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2021-03-10 | 2021-03-12 | 415 | — | $0 | 418 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2021-03-10 | 2021-03-12 | 935 | $60.93 | $57.0K | 19,362 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2021-03-10 | 2021-03-12 | 313 | $60.93 | $19.1K | 17,316 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2021-03-10 | 2021-03-12 | 18 | — | $0 | 17,629 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-03-10 | 2021-03-12 | 980 | — | $0 | 17,611 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2021-03-10 | 2021-03-12 | 391 | $60.93 | $23.8K | 16,631 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2021-03-10 | 2021-03-12 | 184 | — | $0 | 17,022 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-03-10 | 2021-03-12 | 1,062 | — | $0 | 16,838 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2021-03-10 | 2021-03-12 | 119 | $60.93 | $7.3K | 15,776 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2021-03-10 | 2021-03-12 | 36 | — | $0 | 15,895 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-03-10 | 2021-03-12 | 415 | — | $0 | 15,931 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2021-03-10 | 2021-03-12 | 152 | $60.93 | $9.3K | 15,516 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2021-03-10 | 2021-03-12 | 30 | — | $0 | 15,668 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-03-10 | 2021-03-12 | 452 | — | $0 | 15,638 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2021-03-10 | 2021-03-12 | 2,495 | — | $0 | 19,811 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2021-03-10 | 2021-03-12 | 486 | — | $0 | 20,297 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | S Sale | 2020-11-24 | 2020-11-25 | 900 | $63.39 | $57.1K | 15,186 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | S Sale | 2020-05-22 | 2020-05-26 | 3,200 | $61.01 | $195.2K | 16,086 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-03-10 | 2020-03-12 | 451 | — | $0 | 452 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-03-10 | 2020-03-12 | 372 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-03-10 | 2020-03-12 | 2,707 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-03-10 | 2020-03-12 | 415 | — | $0 | 833 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-03-10 | 2020-03-12 | 5,885 | — | $0 | 5,885 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2020-03-10 | 2020-03-12 | 1,062 | — | $0 | 3,186 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-03-10 | 2020-03-12 | 3,923 | — | $0 | 3,923 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2020-03-10 | 2020-03-12 | 238 | — | $0 | 17,854 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-03-10 | 2020-03-12 | 1,062 | — | $0 | 17,616 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2020-03-10 | 2020-03-12 | 143 | $57.93 | $8.3K | 16,554 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2020-03-10 | 2020-03-12 | 20 | — | $0 | 16,697 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-03-10 | 2020-03-12 | 415 | — | $0 | 16,717 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2020-03-10 | 2020-03-12 | 1,077 | $57.93 | $62.4K | 19,286 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2020-03-10 | 2020-03-12 | 51 | — | $0 | 16,484 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-03-10 | 2020-03-12 | 451 | — | $0 | 16,433 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2020-03-10 | 2020-03-12 | 133 | $57.93 | $7.7K | 15,982 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2020-03-10 | 2020-03-12 | 6 | — | $0 | 16,115 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-03-10 | 2020-03-12 | 372 | — | $0 | 16,121 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2020-03-10 | 2020-03-12 | 470 | $57.93 | $27.2K | 17,384 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2020-03-10 | 2020-03-12 | 2,707 | — | $0 | 20,091 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2020-03-10 | 2020-03-12 | 272 | — | $0 | 20,363 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2020-03-10 | 2020-03-12 | 182 | $57.93 | $10.5K | 16,302 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | S Sale | 2019-12-05 | 2019-12-09 | 1,740 | $58.81 | $102.3K | 15,749 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-03-10 | 2019-03-13 | 6,372 | — | $0 | 6,372 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2019-03-10 | 2019-03-13 | 2,196 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-03-10 | 2019-03-13 | 4,248 | — | $0 | 4,248 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2019-03-10 | 2019-03-13 | 415 | — | $0 | 1,248 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2019-03-10 | 2019-03-13 | 451 | — | $0 | 903 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2019-03-10 | 2019-03-13 | 369 | — | $0 | 372 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2019-03-10 | 2019-03-13 | 304 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2019-03-10 | 2019-03-13 | 2,196 | — | $0 | 18,240 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2019-03-10 | 2019-03-13 | 451 | — | $0 | 16,023 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2019-03-10 | 2019-03-13 | 49 | — | $0 | 15,974 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2019-03-10 | 2019-03-13 | 138 | $51.39 | $7.1K | 15,836 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2019-03-10 | 2019-03-13 | 415 | — | $0 | 16,251 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2019-03-10 | 2019-03-13 | 98 | — | $0 | 16,153 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2019-03-10 | 2019-03-13 | 109 | $51.39 | $5.6K | 16,044 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2019-03-10 | 2019-03-13 | 100 | $51.39 | $5.1K | 15,572 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2019-03-10 | 2019-03-13 | 751 | $51.39 | $38.6K | 17,489 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2019-03-10 | 2019-03-13 | 304 | — | $0 | 15,526 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2019-03-10 | 2019-03-13 | 61 | — | $0 | 15,465 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2019-03-10 | 2019-03-13 | 84 | $51.39 | $4.3K | 15,381 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2019-03-10 | 2019-03-13 | 369 | — | $0 | 15,750 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | J Other | 2019-03-10 | 2019-03-13 | 78 | — | $0 | 15,672 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise deriv | 2018-09-03 | 2018-09-05 | 797 | — | $0 | 0 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | F Tax w/h | 2018-09-03 | 2018-09-05 | 273 | $60.55 | $16.5K | 15,222 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | M Exercise | 2018-09-03 | 2018-09-05 | 797 | — | $0 | 15,495 | SEC↗ |